InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,995.54
(
0.38%
)
US TECH 100
20,562.00
(
0.10%
)
Dow Jones
43,988.99
(
0.59%
)
Brent Oil
73.89
(
0.00%
)
Bitcoin
78,660.20
(
2.45%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

gpo344

Send PM Follow Ignore
Followers 1
Posts 225
Boards Moderated 0
Alias Born 06/13/2010

gpo344

Re: biotech_researcher post# 4318

Wednesday, 12/22/2010 6:46:22 PM

Wednesday, December 22, 2010 6:46:22 PM

Post# of 80490
Sure, Ponatinib may be more effective than them all, but Gleevac is still very effective, and so are the others. It could take years to show Ponatinib is the better choice, and even so the others have a large head start. And if they are all 90% effective or more is there room for them all?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up